A patient with an untreated carcinoma of the prostate was admitted with dehydration, stupor and a surprisingly deep hypocalcaemia. The severe hypocalcaemia was largely attributed to extensive osteoblastic activity due to widespread skeletal metastases although contributing factors to the severity of the hypocalcaemia were a relative vitamin D deficiency, hypomagnesaemia and renal impairment, preventing the mounting of an adequate homeostatic response. There was significant clinical and biochemical improvement after antitumour treatment using androgen deprivation, and supplementation with calcium and vitamin D.</p
Paraneoplastic syndromes are generally defined as clinical disorders associated with malignant disea...
The tumor lysis syndrome is recognized by the devel-opment of hyperuricemia, hyperkalemia, hyperphos...
Background: Most patients with advanced prostate cancer develop bone metastases, which often result ...
A patient with an untreated carcinoma of the prostate was admitted with dehydration, stupor and a su...
Calcium metabolism in cancer and hypercalcaemia of malignancy: The balance between bone formation an...
A 65 year old man presented with a two-month history of low back pain and fatigue and urinary sympto...
Abstract One of the most common metabolic abnormalities found in patients with malignancy is hyperca...
Abstract: Bone metabolic disruption that occurs in bone metastatic prostate cancer could lead to dis...
Copyright © 2014 Mohammed Muqeet Adnan et al. This is an open access article distributed under the C...
Most patients with advanced prostate cancer develop bone metastases, which often result in painful a...
Tumor-induced osteomalacia (TIO) is a paraneoplastic bone mineral disturbance related to fibroblast ...
This study was carried out to evaluate the metabolic consequences of osteosclerotic skeletal metasta...
Background - Hypercalcemia of malignancy is relatively common in several cancers. However, in colore...
Urine total hydroxyproline (THP), urine calcium, and serum alkaline phosphatase (SAP) were estimated...
OBJECTIVES: Denosumab is often used in men with advanced prostate cancer to prevent skeletal-related...
Paraneoplastic syndromes are generally defined as clinical disorders associated with malignant disea...
The tumor lysis syndrome is recognized by the devel-opment of hyperuricemia, hyperkalemia, hyperphos...
Background: Most patients with advanced prostate cancer develop bone metastases, which often result ...
A patient with an untreated carcinoma of the prostate was admitted with dehydration, stupor and a su...
Calcium metabolism in cancer and hypercalcaemia of malignancy: The balance between bone formation an...
A 65 year old man presented with a two-month history of low back pain and fatigue and urinary sympto...
Abstract One of the most common metabolic abnormalities found in patients with malignancy is hyperca...
Abstract: Bone metabolic disruption that occurs in bone metastatic prostate cancer could lead to dis...
Copyright © 2014 Mohammed Muqeet Adnan et al. This is an open access article distributed under the C...
Most patients with advanced prostate cancer develop bone metastases, which often result in painful a...
Tumor-induced osteomalacia (TIO) is a paraneoplastic bone mineral disturbance related to fibroblast ...
This study was carried out to evaluate the metabolic consequences of osteosclerotic skeletal metasta...
Background - Hypercalcemia of malignancy is relatively common in several cancers. However, in colore...
Urine total hydroxyproline (THP), urine calcium, and serum alkaline phosphatase (SAP) were estimated...
OBJECTIVES: Denosumab is often used in men with advanced prostate cancer to prevent skeletal-related...
Paraneoplastic syndromes are generally defined as clinical disorders associated with malignant disea...
The tumor lysis syndrome is recognized by the devel-opment of hyperuricemia, hyperkalemia, hyperphos...
Background: Most patients with advanced prostate cancer develop bone metastases, which often result ...